The combination of weight loss, improved insulin sensitivity, and direct hepatic metabolic effects positions Retatrutide as a promising therapeutic for the full spectrum of MASLD, from simple steatosis through steatohepatitis
Eli Lilly also said in a statement it would escape tariffs for three years as part of the agreement with the Trump administration
Summary: Macrogol laxatives (UK equivalent of Miralax) can generally be used safely alongside Wegovy, as there is no contraindication and the medications work through different mechanisms without direct interaction

Additional vulnerability factors may include: Concurrent stressful life circumstances Major life changes, relationship difficulties, or occupational stress may compound any mood effects Inadequate support systems Lack of family, social, or professional psychological support during weight loss treatment Rapid or substantial weight loss Dramatic body composition changes can affect psychological adjustment and body image Polypharmacy Taking multiple medications that may interact or have cumulative effects on mood and cognition Substance use history Previous or current alcohol or drug use may complicate mental health monitoring Younger adults and adolescents may represent a particularly vulnerable group, though Wegovy is not currently licensed for use in individuals under 18 years in the UK

Furthermore, we used a commercial glycolysis antibody panel to detect Pfkp, Pyruvate kinase M1 and M2 (Pkm1, Pkm2), Hexokinase 1, Hexokinase 2 and Pyruvate dehydrogenase 1 subunit (Pdh) by immunoblot analysis